Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
US9150588B2 · kind B2 · utility
3Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2011 |
| Grant date | Oct 6, 2015 |
| Priority date | — |
| Expiry date | Aug 9, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/048
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound having PDE inhibitory represented by formula (1), W1-W2 (1), wherein (i) W1 isand W2 is(ii) W1 isand W2 isor (iii) W1 isand W2 isor a pharmaceutically acceptable salt thereof; and a method of treating or preventing schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.